MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study.

about

MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study.

Item

http://www.wikidata.org/entity/Q48256730

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

MicroRNA expression in SMARCB1 ...... l and molecular genetic study.

@en

MicroRNA expression in SMARCB1 ...... l and molecular genetic study.

@nl

type

Item

label

MicroRNA expression in SMARCB1 ...... l and molecular genetic study.

@en

MicroRNA expression in SMARCB1 ...... l and molecular genetic study.

@nl

prefLabel

MicroRNA expression in SMARCB1 ...... l and molecular genetic study.

@en

MicroRNA expression in SMARCB1 ...... l and molecular genetic study.

@nl

P1476

MicroRNA expression in SMARCB1 ...... l and molecular genetic study.

@en

P2093

Aleš Ryška

http://www.w3.org/2001/XMLSchema#string

Hana Vošmiková

http://www.w3.org/2001/XMLSchema#string

Ivana Baranová

http://www.w3.org/2001/XMLSchema#string

Jana Šatanková

http://www.w3.org/2001/XMLSchema#string

Kateřina Sieglová

http://www.w3.org/2001/XMLSchema#string

Marcela Chmelařová

http://www.w3.org/2001/XMLSchema#string

Milan Vošmik

http://www.w3.org/2001/XMLSchema#string

Pavel Dundr

http://www.w3.org/2001/XMLSchema#string

P2860

SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.

SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.

SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.

Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets.

Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.

MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis.

Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas.

SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.

Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK).

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

P2888

s00428-018-2293-5

P31

scholarly article

P356

10.1007/S00428-018-2293-5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29327137

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression